Sleep Movement Disorder Drug Market

Sleep movement disorders are the disorders disrupting during sleep and generally have undesirable verbal or physical behaviors which frequently result in insomnia and daytime fatigue. Movements during sleep are very common, especially among children.
Sleep Movement Disorder Drug Market contains market size and forecasts of Sleep Movement Disorder Drug in Global, including the following market information:
Global Sleep Movement Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sleep Movement Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Benzodiazepines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sleep Movement Disorder Drug include Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline and BD. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sleep Movement Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sleep Movement Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sleep Movement Disorder Drug Market Segment Percentages, by Type, 2021 (%)
Benzodiazepines
Opioids
Anticonvulsants
Others
Global Sleep Movement Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sleep Movement Disorder Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sleep Movement Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sleep Movement Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sleep Movement Disorder Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sleep Movement Disorder Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cardinal Health
Mylan
Teva
Shermco
Vollin Holdings
Allergan
Pfizer
GlaxoSmithKline
BD